Literature DB >> 15809462

Brief communication: duration of platelet dysfunction after a 7-day course of Ibuprofen.

Neil A Goldenberg1, Linda Jacobson, Marilyn J Manco-Johnson.   

Abstract

BACKGROUND: Despite a paucity of evidence, clinicians routinely advise that patients discontinue using nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, at least 1 week before most surgical procedures.
OBJECTIVE: To define the duration of ibuprofen-induced platelet dysfunction.
DESIGN: Prospective cohort study.
SETTING: Denver/Aurora, Colorado. PARTICIPANTS: 11 healthy adult volunteers. MEASUREMENTS: Individuals were tested at baseline and serially after completion of a 7-day course of ibuprofen (600 mg orally every 8 hours). The platelet function analyzer (PFA-100, Dade Behring, Newark, Delaware), a test that has replaced the bleeding time in many clinical settings, was used.
RESULTS: All participants exhibited normal platelet function before starting ibuprofen. Platelet dysfunction was apparent after completion of the ibuprofen course in 7 of the 11 participants and normalized by 24 hours after the last ibuprofen dose. LIMITATIONS: The sample size in this study was small, and no participants had a major illness. Correlation between PFA-100 results and clinical bleeding has not been established.
CONCLUSIONS: Platelet function seems to normalize within 24 hours after cessation of regular ibuprofen use in healthy individuals. Further studies are warranted to provide a rational basis for timing of NSAID withdrawal in a range of patients undergoing surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809462     DOI: 10.7326/0003-4819-142-7-200504050-00009

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  16 in total

1.  Platelet function analyser (PFA)-100 closure time in the evaluation of non-steroidal anti-inflammatory drug-induced platelet dysfunction in children with bleeding symptoms.

Authors:  Mehmet Akin; Yusuf Polat
Journal:  Blood Transfus       Date:  2012-03-29       Impact factor: 3.443

2.  Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage.

Authors:  Andrew M Naidech; Storm M Liebling; Neil F Rosenberg; Paul F Lindholm; Richard A Bernstein; H Hunt Batjer; Mark J Alberts; Hau C Kwaan
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

3.  Drug therapy in dental practice: nonopioid and opioid analgesics.

Authors:  Daniel E Becker; James C Phero
Journal:  Anesth Prog       Date:  2005

4.  Slippery platelet syndromes in subdural hematoma.

Authors:  Paul Taylor Akins; Kern Hayden Guppy; Kamran Sahrakar; Mark Wade Hawk
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

5.  Long-term assessment of aspirin desensitization shows successful bridging with non-aspirin nonsteroidal anti-inflammatory drugs for procedures.

Authors:  Toan Do; Ethan Canty; Puneet Bajaj; Faoud Ishmael; Timothy Craig
Journal:  Allergy Asthma Proc       Date:  2019-09-01       Impact factor: 2.587

Review 6.  Pain management: Part 1: Managing acute and postoperative dental pain.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2010

7.  NSAIDs and bleeding in periodontal surgery.

Authors:  Sanyuktha Shetty; Sharath K; Biju Thomas; Nitin Shetty; Arvind Shetty; Devanand Shetty
Journal:  J Clin Diagn Res       Date:  2014-05-15

Review 8.  Adverse drug reactions in dental practice.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2014

Review 9.  Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine.

Authors:  Peter Le Roux; David K Menon; Giuseppe Citerio; Paul Vespa; Mary Kay Bader; Gretchen M Brophy; Michael N Diringer; Nino Stocchetti; Walter Videtta; Rocco Armonda; Neeraj Badjatia; Julian Böesel; Randall Chesnut; Sherry Chou; Jan Claassen; Marek Czosnyka; Michael De Georgia; Anthony Figaji; Jennifer Fugate; Raimund Helbok; David Horowitz; Peter Hutchinson; Monisha Kumar; Molly McNett; Chad Miller; Andrew Naidech; Mauro Oddo; DaiWai Olson; Kristine O'Phelan; J Javier Provencio; Corinna Puppo; Richard Riker; Claudia Robertson; Michael Schmidt; Fabio Taccone
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

Review 10.  Monitoring of hematological and hemostatic parameters in neurocritical care patients.

Authors:  Andrew M Naidech; Monisha A Kumar
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.